Filter posts

IP Sessions at BIO 2015: The Evolving Landscape of Patentable Subject Matter

The IP Track at BIO 2015 had a number of incredible educational sessions concerning the …

This Independence Day, Let’s Thank the Inventors

Happy Birthday AMERICA! That’s right, this Saturday is July 4. And yes, that means what …

2015 State GE Food Products Labeling Legislative Scorecard

State legislatures regularly tackle contentious issues.  In recent years, however, few policy matters have been …

IP Sessions at BIO 2015: The Impact of the Inter Partes Review on (BIO)Pharma

The Intellectual Property Track at the BIO International Convention was a chance for IP thought …

FDA Acts on Biosimilars

The Biologics Price Competition and Innovation Act (BPCIA) deferred to the Food and Drug Administration …

Rep. Pompeo’s GMO Labeling Bill Receives Broad Support from Lawmakers

On June 18, 2015, the House of Representatives Energy and Commerce Health subcommittee held a …

Complexities of Rare Diseases Take the Spotlight at BIO

Global Genes Founder & CEO Nicole Boice opened the BIO 2015 Orphan & Rare Disease …

Outdated Payments Systems Aren’t Keeping Pace With Medical Innovation

We are experiencing an era of rapid medical progress thanks to the accelerated pace at …

Biosimilars at the Federal Circuit – Can the Parties Be Compelled to Dance?

In 2009, Congress passed the Biologics Price Competition and Innovation Act (“BPCIA”), which for the first …

Sen Menendez Asks SEC to Investigate IPR Abuses

New Jersey Senator Bob Menendez has asked the Securities and Exchange Commissioner (SEC) to investigate …